Cambridge, Massachusetts Friday, October 24, 2025, 18:00 Hrs [IST] ...

NU Hospitals with Medlern and Laerdal Medical to enhance clinical training through advanced modular skills training: Our Bureau, Bengaluru Friday, October 24, 2025, 17:45 Hrs [IST ...

Vaayu Chest and Sleep Specialty Center’s REVIVE 2025 underscores need for multidisciplinary collaboration: Our Bureau, Bengaluru Friday, October 24, 2025, 17:30 Hrs [IST] Vaayu ...

Forlong Biotechology inks agreement with Shanghai Henlius Biotech to develop cancer immunotherapy: Shanghai Friday, October 24, 2025, 17:00 Hrs [IST] Forlong Biotechnology, a clin ...

Horus Pharma inks agreement to commercialize Formycon’s aflibercept biosimilar FYB203 under the brand name Baiama across Key European Markets including its home market France ...

Non-profit patient advocacy groups, patient groups and others in various parts of the world have come together to launch a community-run buyers' club to access a new generic version of a lifesaving ...

SecondWave Systems to expanded Series A syndicate to speed up development of ultrasound-based anti-inflammatory treatment: St. Paul, Minnesota Friday, October 24, 2025, 15:00 Hrs ...

Emeryville, California Friday, October 24, 2025, 14:00 Hrs [IST] ...

US FDA grants fast track designation to AnnJi Pharma’s AJ201, a first-in-class therapy for Kenndy’s disease: Taipei City, Taiwan Friday, October 24, 2025, 13:00 Hrs [IST] AnnJ ...

Global pharma major Lupin Limited (Lupin) announced the launch of an authorized generic version of Ravicti (glycerol phenylbutyrate) oral liquid, 1.1g/mL, in the United States. Glycerol phenylbutyrate ...

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital PCR high complexity assays: Louisville, Colorado Friday, October 24, 2025, 12:00 ...

The 7th Annual Pharma Manufacturing & Automation Convention (PM&AC) 2025, co-located with the Pharma Manufacturing & ...